Methyl 2-(3S)-3-3-(1E)-2-(7-chloro-2-quinolinyl)ethenylphenyl-3-hydroxypropylbenzoate丨CAS 181139-72-0

Methyl 2-(3S)-3-3-(1E)-2-(7-chloro-2-quinolinyl)ethenylphenyl-3-hydroxypropylbenzoate is a complex pharmaceutical intermediate primarily used in drug discovery and medicinal chemistry. It serves as a key building block in the synthesis of bioactive quinoline derivatives and small-molecule therapeutics, particularly in programs targeting cardiovascular, neurological, or inflammatory pathways. The compound is applied in structure–activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties of drug candidates. Its hydroxypropyl and ester functionalities allow further derivatization, enabling chemists to generate diverse analogues for preclinical evaluation. Additionally, it is used in mechanistic studies, enzyme inhibition assays, and receptor-ligand interaction research to explore pharmacodynamics and biological activity in early-stage drug development.

The benefits of this compound arise from its multifunctional structure, stereochemical precision, and synthetic versatility. The 3S configuration ensures defined stereochemistry for improved biological activity and selectivity in drug candidates. Its hydroxypropyl and ester groups allow selective chemical transformations, supporting multi-step synthesis of complex molecules with high yield and reproducibility. The quinoline and phenyl moieties contribute to receptor binding and pharmacophore design, making the molecule a valuable tool for medicinal chemists. The compound exhibits good stability under standard laboratory conditions and compatibility with common organic solvents, facilitating reliable handling, storage, and incorporation into advanced synthetic routes.